Should we prescribe diuretics for patients with prediabetes and hypertension?BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a679 (Published 21 August 2008) Cite this as: BMJ 2008;337:a679
- Bruce Arroll, professor ,
- Timothy Kenealy, associate professor ,
- C Raina Elley, senior lecturer
- 1Department of General Practice and Primary Health Care, University of Auckland, Private Bag 92019, Auckland, New Zealand 1142
- Correspondence to: B Arroll
- Accepted 4 April 2008
The uncertainty arises from the findings of the large randomised controlled ALLHAT 2002 trial (31 512 people 55 years or older with hypertension and one other risk factor for cardiovascular disease), in which the thiazide-like diuretic chlortalidone seemed to increase some cardiac risk factors, including the rate of developing diabetes. After four years of follow-up in those who had a normal fasting blood glucose at baseline, 302 (11.6%) people taking chlortalidone, 154 (9.8%) of those taking amlodipine (a calcium channel blocker), and 119 (8.1%) of those taking lisinopril (an angiotensin converting enzyme inhibitor) had fasting blood glucose concentrations of ≥7 mmol/l (P<0.001).1 Diuretics are known to achieve long term cardiovascular results as good as, or better than, alternative antihypertensives—at least in people aged 55 years or older. But clinicians may not initially treat patients with prediabetes and hypertension with a diuretic because they worry that the induced diabetes might result in a worse outcome than if they prescribed a different class of antihypertensive.
What is the evidence of the uncertainty?
International guidelines give conflicting advice, presumably because of this uncertainty. The National Institute for Health and Clinical Excellence (NICE) advises general practitioners in the United Kingdom to use diuretics and calcium channel blockers as first line treatments in patients over 55 years and angiotensin converting enzyme inhibitors in those under 55. Diuretics are not recommended in the younger group partly because of concern about …